Good Review Management Principles and Practices for New Drug Applications and Biologics License Applications: Draft Guidance for Industry and Review Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 25, 2018
April 22, 2020
d4716fc0-3257-42cf-a1c9-4c6c329dd8d1
Related Documents
Pediatric Drug Development Under the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act: Scientific Considerations
Guidance DocumentMay 17, 2023Center for Drug Evaluation and Research
Translation of Good Laboratory Practice Study Reports: Questions and Answers
Guidance DocumentNovember 21, 2023Center for Drug Evaluation and Research
Early Alzheimer’s Disease: Developing Drugs for Treatment
Guidance DocumentMarch 12, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.